Symbol: |
LYVE1
|
Description: |
lymphatic vessel endothelial hyaluronan receptor 1 [Source:HGNC Symbol;Acc:14687]
|
Location: |
Chr11:10578513-10633236[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:142
Gene |
Compound |
Gen_sig |
Exp_pattern |
LYVE1 |
NSC 667875 |
0.036 |
Down |
LYVE1 |
NSC 670314 |
0.037 |
Down |
LYVE1 |
NSC 670783 |
0.047 |
Down |
LYVE1 |
NSC 670788 |
0.031 |
Down |
LYVE1 |
Benzoic acid, 2,4-dichloro-, 6-acetyl-1,2,3,4-tetrahydro- 4-oxo-1,3-diphenyl-2-thioxothieno[2,3-d]pyrimidin-5-yl ester |
0.009 |
Up |
LYVE1 |
2-Iodoestradiol |
0.017 |
Up |
LYVE1 |
NSC 671689 |
0.012 |
Up |
LYVE1 |
3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione |
0.014 |
Up |
LYVE1 |
7-O-.beta.-D-Galactosyl-befeldin A |
0.004 |
Up |
LYVE1 |
NSC 672261 |
0.017 |
Down |
LYVE1 |
NSC 674576 |
0.006 |
Down |
LYVE1 |
5-Hydroxy-7-amino(1,2,3)thiadiazole[5,4-d]pyrimidine |
0.014 |
Up |
LYVE1 |
2-Naphthacenecarboxamide, N-[(6,7-dihydro-7-oxo-v-triazolo[4,5-d]pyrimidin-5-ylamino)methyl]-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo- |
0.004 |
Up |
LYVE1 |
Herveline O |
0.005 |
Up |
LYVE1 |
NSC 677166 |
0.004 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:27
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|